>>Back
Sanofi nabs FDA approval for Kynamro, despite safety concerns
  • Publisher：
  • Publication：2013/1/31
The FDA came through with an approval for Kynamro, a treatment for a rare form of high cholesterol from Sanofi's ($SNY) Genzyme unit. But the agency's blessing came with some strings attached: Four post-marketing studies and long-term safety tracking.

Excipients

PHEXCOM is a registered trademark of Shanghai Phexcom Information Technology Co.,Ltd. Copyright 2009-2025 Shanghai Phexcom Information Technology Co.,Ltd. All rights reserved.
版权所有:辅料网 ICP备案编号： 沪ICP备09013362号-1